We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Real-Time Mobile Laboratory Developed for Needle Device

By LabMedica International staff writers
Posted on 12 Oct 2015
A truly practical lab-on-a-chip (LOC) system for point-of-care testing (POCT) hepatotoxicity assessment necessitates the embodiment of full-automation, ease-of-use and “sample-in-answer-out” diagnostic capabilities.

A laboratory in a needle device has been developed that could provide instant results to routine laboratory tests, accelerating treatment and diagnosis by days. More...
This single, self-contained medical device will be effective, for example, in quickly detecting liver toxicity which is a common side effect of chemotherapy. This device will test toxicity in 30 minutes while current liver toxicity tests take several days due to multiple steps required before a physician interprets the test results and communicates them to the patient.

Scientists at Houston Methodist Research Institute (TX, USA) working with colleagues in Singapore developed an integrated LOC system that is somewhat close to a practical POCT hepatotoxicity assessment device as it embodies both tissue sample preparation and multiplex real-time reverse transcriptase polymerase chain reaction (RT-PCR). It features semi-automation, is relatively easy to use, and has “sample-in-answer-out” capabilities for multiplex gene expression analysis.

The tissue sample preparation module incorporated both a micro-homogenizer and surface-treated paramagnetic microbeads that yielded high-purity messenger ribonucleic (mRNA) extracts— considerably better than manual means of extraction. A primer preloading surface treatment procedure and the single-loading inlet on the multiplex real-time RT-PCR module simplified off-chip handling procedures for ease-of-use. Elevations in the two examined gene markers of liver toxicity were then accurately detected and consistent with previously known changes, indicating that lab in a needle is an appropriate diagnostic option.

Joseph S. Chang, PhD, a professor at Nanyang Technological University (Singapore) and a senior author of the study said, “What we have proven is when the doctor takes a blood or liver sample, the sample can be prepared and analyzed using lab on a chip methods which eliminates the need for wet laboratory work and experts. Our method significantly reduces time, manpower and costs and yet has the same accurate results.” The study was published on September 2, 2105 in the journal Lab on a Chip.

Related Links:

Houston Methodist Research Institute
Nanyang Technological University 



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.